PROCEPT BioRobotics Corp
PRCT- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001588978
In the last 90 days, PROCEPT BioRobotics Corp insiders filed 1 open-market purchase and 3 sales; 253 institutions reported holding it in 13F filings for Q2 2026, worth $1.24B in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding PROCEPT BioRobotics Corp changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 58 | 1 | 96 | +39 |
| Shares | 31.0M | 1.12K | 34.9M | +3.89M (+12.5%) |
| Value | $1.08B | $39.0K | $1.14B | +$55.9M (+5.2%) |
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (44)
Institutions that held PROCEPT BioRobotics Corp at the end of Q2 2022 but not at the end of Q1 2022.
Sold out (5)
Institutions that held PROCEPT BioRobotics Corp at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Dumac, Inc. | 165,179 | $5.78M |
| HRT Financial LP | 51,282 | $1.79M |
| ExodusPoint Capital Management, LP | 16,863 | $590.0K |
| Ergoteles LLC | 10,755 | $376.0K |
| Point72 Hong Kong Ltd | 341 | $12.0K |
Not filed for Q2 2022 yet (1)
Institutions that held PROCEPT BioRobotics Corp at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Amalgamated Financial Corp. | 1,124 | $39.0K |